false
Robert Bauer
Robert Bauer is an Executive Director of Operational Strategy at Precision with over 20 years of clinical trial operations experience from both the sponsor and CRO perspectives. He has led teams in the conduct of trials from Phase I through IV and has experience across a wide variety of trial designs. Bob has experience across many therapeutic areas some of which include rare diseases, oncology, depression, schizophrenia, and substance use disorders.
-
Read: Clinical Trial Trends: Early Phase Rare Oncology Clinical Trial Trends: Early Phase Rare Oncology
-
Read: Clinical Trial Trends: Rare Oncology vs Non-Oncology Discover -
Read: Clinical Trial Trends: Rare Cardiovascular Discover -
Read: Clinical Trial Trends: Rare Autoimmune Discover -
Read: Clinical Trial Trends: Rare Oncology Discover -
Read: Clinical Trial Trends: Rare Metabolic Discover -
Read: Clinical Trial Trends: Rare Pediatric Discover -
Read: Clinical Trial Trends: Rare CNS Discover -
Read: Unpacking FDA’s Draft Guidance on Psychedelic Research for Clinical Success Discover
Loading...
You've reach the end